9,10-dimethyl-1,2-benzanthracene and ER-Negative PR-Negative HER2-Negative Breast Cancer

9,10-dimethyl-1,2-benzanthracene has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gaspar, BL; Katare, OP; Kesharwani, P; Khurana, RK; Kumar, R; Singh, B; Singh, KK; Welsby, G; Welsby, P	1
Aparicio, S; Caldas, C; Chen, X; Chin, SF; Choon Lee, S; Copeland, NG; Futreal, A; Hadi, F; Jenkins, NA; Khaled, WT; Liu, P; Raza Ali, H; Rueda, OM; Stingl, J; Stratton, M; Wang, J; Watson, CJ; Yu, Y	1

Other Studies

2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Clathrin-mediated endocytic uptake of PUFA enriched self-nanoemulsifying lipidic systems (SNELS) of an anticancer drug against triple negative cancer and DMBA induced preclinical tumor model. Materials science & engineering. C, Materials for biological applications, 2018, Oct-01, Volume: 91 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Clathrin; Docetaxel; Emulsions; Endocytosis; Fatty Acids, Unsaturated; Female; Humans; Lipids; Macrophages; Mice; Nanoparticles; Particle Size; Rats, Wistar; RAW 264.7 Cells; Static Electricity; Taxoids; Temperature; Time Factors; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2018
BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells. Nature communications, 2015, Jan-09, Volume: 6 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Mammary Glands, Animal; Mice; Neoplasm Transplantation; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Prognosis; Repressor Proteins; Stem Cells; Triple Negative Breast Neoplasms	2015

Article

Year

Clathrin-mediated endocytic uptake of PUFA enriched self-nanoemulsifying lipidic systems (SNELS) of an anticancer drug against triple negative cancer and DMBA induced preclinical tumor model.

Materials science & engineering. C, Materials for biological applications, 2018, Oct-01, Volume: 91

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Clathrin; Docetaxel; Emulsions; Endocytosis; Fatty Acids, Unsaturated; Female; Humans; Lipids; Macrophages; Mice; Nanoparticles; Particle Size; Rats, Wistar; RAW 264.7 Cells; Static Electricity; Taxoids; Temperature; Time Factors; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2018

BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells.

Nature communications, 2015, Jan-09, Volume: 6

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Mammary Glands, Animal; Mice; Neoplasm Transplantation; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Prognosis; Repressor Proteins; Stem Cells; Triple Negative Breast Neoplasms

2015